[1]
Roggeri, D.P. et al. 2014. Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy. Farmeconomia. Health economics and therapeutic pathways. 15, 4 (Dec. 2014), 113–127. DOI:https://doi.org/10.7175/fe.v15i4.968.